Jupiter Medical Center Adjusts Visitor Policy, Elective Procedures

Jupiter Medical Center today announced an update to its visitor policy to allow only one healthy visitor at a time, per patient.

Jupiter Medical Center advises visitors will be screened for potential exposure, travel history and upper respiratory tract symptoms. This new policy went into effect on Wednesday, March 18, and will remain in place until further notice.

Jupiter Medical Center is also in the process of rescheduling non-urgent, elective surgeries. This measure will minimize any potential spread among patients, as well as reduce the risk of exposure to team members and frontline providers. Jupiter Medical Center will continue to perform non-elective, urgent and emergency surgeries.

“In accordance with the Centers for Disease Control (CDC) and the American College of Surgeons recommendations, we are rescheduling elective surgeries to protect the health of our patients and caregivers at this time,” said Dr. Amit Rastogi, president and CEO of Jupiter Medical Center. “We recognize the impact on those patients whose procedures are being delayed and certainly look forward to amending our policy as events warrant.”

Jupiter Medical Center continues to conduct multidisciplinary training drills in preparation for screening, diagnosing, isolating and treating any potential cases of COVID-19, as well as ensuring the proper use of personal protective equipment in accordance with the Centers for Disease Control and Prevention recommended guidelines.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy